Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.

Source:http://linkedlifedata.com/resource/pubmed/id/9114154

Download in:

View as

General Info

PMID
9114154